Summer 2013 Vol. 23, No. 2 Research Edition
MAPS Forum on Bluelight Launched
June 2013 marked the official launch of the new MAPS Forums on Bluelight (bluelight.ru), the world’s most popular open information and discussion board about psychedelics and other drugs. The forums provide a venue for informed conversations about the risks and benefits of psychedelics and marijuana. MAPS Forums include the MAPS Discussion, Clinical Psychedelic Research and Medicine, and Psychedelic Harm Reduction. As MAPS Founder Rick Doblin wrote in his welcome letter, “Bringing together MAPS and Bluelight to host these Forums is a notable step forward in the advancement of public education about psychedelics.”
MAPS Seeks Funding from National Institute of Mental Health
We are preparing a proposal for funding from the National Institute of Mental Health (NIMH). Our NIMH grant proposal will request support for a small “sub-study” to collect additional data from subjects already participating in one of our Phase 2 trials of MDMA-assisted psychotherapy for PTSD. We are planning to submit the grant proposal in February 2014, after we have collected additional data in order to strengthen the grant application. A successful application in 2014 could lead to a larger award for Phase 3 studies in the future. It is not unusual for NIHM to make large-sum multi-year grants.
